Product Description

🔹 Product Overview
Fulveser 250 mg/5 mL Vial is a prescription anticancer medicine used in the treatment of certain types of advanced breast cancer in postmenopausal women.
Contains Fulvestrant 250 mg/5 mL, an estrogen receptor antagonist that helps slow the growth and spread of hormone-sensitive cancer cells.
Commonly prescribed for hormone receptor-positive (HR+), HER2-negative locally advanced or metastatic breast cancer.

🔹 Key Uses
Treatment of HR-positive advanced breast cancer
Management of metastatic breast cancer in postmenopausal women
Used when breast cancer progresses following prior endocrine therapy
May be used in combination with other targeted anticancer therapies as advised by an oncologist

🔹 Composition
Active ingredient: Fulvestrant 250 mg/5 mL
Belongs to the class of estrogen receptor antagonists
Used in hormonal therapy for breast cancer

🔹 How It Works
Blocks and degrades estrogen receptors present on breast cancer cells.
Reduces the effect of estrogen that promotes tumor growth.
Helps slow down or stop the progression of hormone-dependent breast cancer.

🔹 Key Benefits
Effective hormonal therapy for breast cancer
Targets estrogen-dependent cancer cells
Helps delay disease progression
May improve treatment outcomes in advanced disease
Convenient administration under healthcare supervision

🔹 Dosage and Administration
Administered only by a qualified healthcare professional.
Given as an intramuscular injection into the buttock muscle.
The dosing schedule is determined by the treating oncologist.
Do not self-administer this medicine.

🔹 Possible Side Effects
Injection site pain or swelling
Nausea
Headache
Fatigue or weakness
Joint and muscle pain
Hot flashes
Vomiting

🔹 Precautions
Use under strict oncologist supervision.
Not recommended during pregnancy or breastfeeding.
Inform your doctor about liver disease, bleeding disorders, or osteoporosis.
Effective contraception may be advised during treatment.
Regular monitoring and follow-up appointments are essential.